TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Scienta Omicron AB
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
154,935
|
99,985
|
70,794 |
| Financial expenses |
1,719
|
9,001
|
4,232 |
| Earnings before taxes |
29,005
|
-1,862
|
-12,430 |
| EBITDA |
35,175
|
9,641
|
-7,229 |
| Total assets |
70,811
|
63,434
|
94,824 |
| Current assets |
58,269
|
51,022
|
84,627 |
| Current liabilities |
54,684
|
56,062
|
84,590 |
| Equity capital |
14,127
|
4,372
|
6,234 |
| - share capital |
425
|
425
|
425 |
| Employees (average) |
31
|
25
|
25 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
20.0%
|
6.9%
|
6.6% |
| Turnover per employee |
4,998
|
3,999
|
2,832 |
| Profit as a percentage of turnover |
18.7%
|
-1.9%
|
-17.6% |
| Return on assets (ROA) |
43.4%
|
11.3%
|
-8.6% |
| Current ratio |
106.6%
|
91.0%
|
100.0% |
| Return on equity (ROE) |
205.3%
|
-42.6%
|
-199.4% |
| Change turnover |
54,950
|
29,191
|
-8,501 |
| Change turnover % |
55%
|
41%
|
-11% |
| Chg. No. of employees |
6
|
0
|
-5 |
| Chg. No. of employees % |
24%
|
0%
|
-17% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.